JACC in a Flash | SGLT2 Inhibitors Protective Effect on AS Progression, More

Featured topics and Editors' Picks from all of ACC's JACC Journals.

JACC: Cardiovascular Interventions
Exposure-Dependent Protective Effect of SGLT2 Inhibitors on AS Progression?

SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis (AS), according to a study published in JACC: Cardiovascular Interventions.

JACC: Clinical Electrophysiology
Does a History of CVD Affect Chance of SCD?

Patients with a history of cardiovascular disease, compared with those without, had a higher incidence of sudden cardiac death (SCD), according to a study of 5.5 million Danish citizens, published in JACC: Clinical Electrophysiology.

JACC: Heart Failure
Prior HF Influences Prognostic Implications of AFib in Patients Hospitalized For HF

A history of prior heart failure (HF) was found to influence prognostic implications of atrial fibrillation (AFib) in patients hospitalized for HF, with permutations of prior HF, prior AFib and AFib as presenting rhythm differentiating outcome, according to a study in JACC: Heart Failure.

JACC: Cardiovascular Interventions
How Does TR Disease Stage Impact 1-Year Mortality After T-TEER?

Among patients with intermediate stage significant tricuspid regurgitation (TR), one-year survival was higher when treated with tricuspid transcatheter edge-to-edge-repair (T-TEER) compared with conservative treatment, according to a study published in JACC: Cardiovascular Interventions. This survival benefit was not observed in patients at early or advanced stages of disease.

JACC: Cardiovascular Imaging
Position Statement Expands Definition of High-Risk Plaque

The definition of a high-risk plaque should be expanded beyond the traditional focus on plaque rupture and a thin-cap fibroatheroma in the setting of acute coronary syndromes (ACS), according to a new JACC: Cardiovascular Imaging Position Statement published in that journal.

JACC: Advances
ICHOM Develops First Standardized Outcomes Dataset in Valve Disease

A unique international task force, comprised of representatives from cardiology and cardiothoracic societies as well as patient representatives, has developed the first standardized set of measures for heart valve disease (HVD) that moves from procedure- to patient-centered outcomes regardless of treatment type, according to a document by the International Consortium for Health Outcomes Measurement (ICHOM) published in JACC: Advances.

Resources

Clinical Topics: Acute Coronary Syndromes, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Valvular Heart Disease, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure

Keywords: Cardiology Magazine, ACC Publications, Sodium-Glucose Transporter 2 Inhibitors, Aortic Valve Stenosis, Retrospective Studies, Sclerosis, Death, Sudden, Cardiac, Denmark, Cardiovascular Diseases, Atrial Fibrillation, Heart Failure, Tricuspid Valve Insufficiency, Plaque, Atherosclerotic, Acute Coronary Syndrome, Thrombosis, Outcome Assessment, Health Care, Heart Valve Diseases, Reference Standards, Benchmarking